Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
IRIS
Background: Empty pelvis syndrome (EPS) is a significant source of morbidity following pelvic exenteration (PE), but is undefined. EPS outcome reporting and descriptors of radicality of PE are inconsistent; therefore, the best approaches for prevention are unknown. To facilitate future research into EPS, the aim of this study is to define a measurable core outcome set, core descriptor set and written definition for EPS. Consensus on strategies to mitigate EPS was also explored. Method: Three-stage consensus methodology was used: longlisting with systematic review, healthcare professional event, patient engagement, and Delphi-piloting; shortlisting with two rounds of modified Delphi; and a confirmatory stage using a modified nominal group technique. This included a selection of measurement instruments, and iterative generation of a written EPS definition. Results: One hundred and three and 119 participants took part in the modified Delphi and consensus meetings, respectively. This encompassed international patient and healthcare professional representation with multidisciplinary input. Seventy statements were longlisted, seven core outcomes (bowel obstruction, enteroperineal fistula, chronic perineal sinus, infected pelvic collection, bowel obstruction, morbidity from reconstruction, re-intervention, and quality of life), and four core descriptors (magnitude of surgery, radiotherapy-induced damage, methods of reconstruction, and changes in volume of pelvic dead space) reached consensus-where applicable, measurement of these outcomes and descriptors was defined. A written definition for EPS was agreed. Conclusions: EPS is an area of unmet research and clinical need. This study provides an agreed definition and core data set for EPS to facilitate further research.
The empty pelvis syndrome: a core data set from the PelvEx collaborative
null, null;Mirnezami, A H;Drami, I;Glyn, T;Sutton, P A;Tiernan, J;Behrenbruch, C;Guerra, G;Waters, P S;Woodward, N;Applin, S;Charles, S J;Rose, S A;Denys, A;Pape, E;van Ramshorst, G H;Baker, D;Bignall, E;Blair, I;Davis, P;Edwards, T;Jackson, K;Leendertse, P G;Love-Mott, E;MacKenzie, L;Martens, F;Meredith, D;Nettleton, S E;Trotman, M P;van Hecke, J J M;Weemaes, A M J;Abecasis, N;Angenete, E;Aziz, O;Bacalbasa, N;Barton, D;Baseckas, G;Beggs, A;Brown, K;Buchwald, P;Burling, D;Burns, E;Caycedo-Marulanda, A;Chang, G J;Coyne, P E;Croner, R S;Daniels, I R;Denost, Q D;Drozdov, E;Eglinton, T;Espín-Basany, E;Evans, M D;Flatmark, K;Folkesson, J;Frizelle, F A;Gallego, M A;Gil-Moreno, A;Goffredo, P;Griffiths, B;Gwenaël, F;Harris, D A;Iversen, L H;Kandaswamy, G V;Kazi, M;Kelly, M E;Kokelaar, R;Kusters, M;Langheinrich, M C;Larach, T;Lydrup, M L;Lyons, A;Mann, C;McDermott, F D;Monson, J R T;Neeff, H;Negoi, I;Ng, J L;Nicolaou, M;Palmer, G;Parnaby, C;Pellino, G;Peterson, A C;Quyn, A;Rogers, A;Rothbarth, J;Abu Saadeh, F;Saklani, A;Sammour, T;Sayyed, R;Smart, N J;Smith, T;Sorrentino, L;Steele, S R;Stitzenberg, K;Taylor, C;Teras, J;Thanapal, M R;Thorgersen, E;Vasquez-Jimenez, W;Waller, J;Weber, K;Wolthuis, A;Winter, D C;Brangan, G;Vimalachandran, D;Aalbers, A G J;Abdul Aziz, N;Abraham-Nordling, M;Akiyoshi, T;Alahmadi, R;Alberda, W;Albert, M;Andric, M;Angeles, M;Antoniou, A;Armitage, J;Auer, R;Austin, K K;Aytac, E;Baker, R P;Bali, M;Baransi, S;Bebington, B;Bedford, M;Bednarski, B K;Beets, G L;Berg, P L;Bergzoll, C;Biondo, S;Boyle, K;Bordeianou, L;Brecelj, E;Bremers, A B;Brunner, M;Bui, A;Burgess, A;Burger, J W A;Campain, N;Carvalhal, S;Castro, L;Ceelen, W;Chan, K K L;Chew, M H;Chok, A K;Chong, P;Christensen, H K;Clouston, H;Collins, D;Colquhoun, A J;Constantinides, J;Corr, A;Coscia, M;Cosimelli, M;Cotsoglou, C;Damjanovic, L;Davies, M;Davies, R J;Delaney, C P;de Wilt, J H W;Deutsch, C;Dietz, D;Domingo, S;Dozois, E J;Duff, M;Egger, E;Enrique-Navascues, J M;Espín-Basany, E;Eyjólfsdóttir, B;Fahy, M;Fearnhead, N S;Fichtner-Feigl, S;Fleming, F;Flor, B;Foskett, K;Funder, J;García-Granero, E;García-Sabrido, J L;Gargiulo, M;Gava, V G;Gentilini, L;George, M L;George, V;Georgiou, P;Ghosh, A;Ghouti, L;Giner, F;Ginther, N;Glover, T;Golda, T;Gomez, C M;Harris, C;Hagemans, J A W;Hanchanale, V;Harji, D P;Helbren, C;Helewa, R M;Hellawell, G;Heriot, A G;Hochman, D;Hohenberger, W;Holm, T;Holmström, A;Hompes, R;Hornung, B;Hurton, S;Hyun, E;Ito, M;Jenkins, J T;Jourand, K;Kaffenberger, S;Kapur, S;Kanemitsu, Y;Kaufman, M;Kelley, S R;Keller, D S;Kersting, S;Ketelaers, S H J;Khan, M S;Khaw, J;Kim, H;Kim, H J;Kiran, R;Koh, C E;Kok, N F M;Kontovounisios, C;Kose, F;Koutra, M;Kraft, M;Kristensen, H Ø;Kumar, S;Lago, V;Lakkis, Z;Lampe, B;Larsen, S G;Larson, D W;Law, W L;Laurberg, S;Lee, P J;Limbert, M;Loria, A;Lynch, A C;Mackintosh, M;Mantyh, C;Mathis, K L;Margues, C F S;Martinez, A;Martling, A;Meijerink, W J H J;Merchea, A;Merkel, S;Mehta, A M;McArthur, D R;McCormick, J J;McGrath, J S;McPhee, A;Maciel, J;Malde, S;Manfredelli, S;Mikalauskas, S;Modest, D;Morton, J R;Mullaney, T G;Navarro, A S;Neto, J W M;Nguyen, B;Nielsen, M B;Nieuwenhuijzen, G A P;Nilsson, P J;Nordkamp, S;O’Dwyer, S T;Paarnio, K;Pappou, E;Park, J;Patsouras, D;Peacock, O;Pfeffer, F;Piqeur, F;Pinson, J;Poggioli, G;Proud, D;Quinn, M;Oliver, A;Radwan, R W;Rajendran, N;Rao, C;Rasheed, S;Rasmussen, P C;Rausa, E;Regenbogen, S E;Reims, H M;Renehan, A;Rintala, J;Rocha, R;Rochester, M;Rohila, J;Rottoli, M;Roxburgh, C;Rutten, H J T;Safar, B;Sagar, P M;Sahai, A;Schizas, A M P;Schwarzkopf, E;Scripcariu, D;Scripcariu, V;Seifert, G;Selvasekar, C;Shaban, M;Shaikh, I;Shida, D;Simpson, A;Skeie-Jensen, T;Smart, P;Smith, J J;Solbakken, A M;Solomon, M J;Sørensen, M M;Spasojevic, M;Steffens, D;Stocchi, L;Stylianides, N A;Swartling, T;Sumrien, H;Swartking, T;Takala, H;Tan, E J;Taylor, D;Tejedor, P;Tekin, A;Tekkis, P P;Thaysen, H V;Thurairaja, R;Toh, E L;Tsarkov, P;Tolenaar, J;Tsukada, Y;Tsukamoto, S;Tuech, J J;Turner, G;Turner, W H;Tuynman, J B;Valente, M;van Rees, J;van Zoggel, D;Vásquez-Jiménez, W;Verhoef, C;Vierimaa, M;Vizzielli, G;Voogt, E L K;Uehara, K;Wakeman, C;Warrier, S;Wasmuth, H H;Weiser, M R;Westney, O L;Wheeler, J M D;Wild, J;Wilson, M;Yano, H;Yip, B;Yip, J;Yoo, R N;Zappa, M A
2024-01-01
Abstract
Background: Empty pelvis syndrome (EPS) is a significant source of morbidity following pelvic exenteration (PE), but is undefined. EPS outcome reporting and descriptors of radicality of PE are inconsistent; therefore, the best approaches for prevention are unknown. To facilitate future research into EPS, the aim of this study is to define a measurable core outcome set, core descriptor set and written definition for EPS. Consensus on strategies to mitigate EPS was also explored. Method: Three-stage consensus methodology was used: longlisting with systematic review, healthcare professional event, patient engagement, and Delphi-piloting; shortlisting with two rounds of modified Delphi; and a confirmatory stage using a modified nominal group technique. This included a selection of measurement instruments, and iterative generation of a written EPS definition. Results: One hundred and three and 119 participants took part in the modified Delphi and consensus meetings, respectively. This encompassed international patient and healthcare professional representation with multidisciplinary input. Seventy statements were longlisted, seven core outcomes (bowel obstruction, enteroperineal fistula, chronic perineal sinus, infected pelvic collection, bowel obstruction, morbidity from reconstruction, re-intervention, and quality of life), and four core descriptors (magnitude of surgery, radiotherapy-induced damage, methods of reconstruction, and changes in volume of pelvic dead space) reached consensus-where applicable, measurement of these outcomes and descriptors was defined. A written definition for EPS was agreed. Conclusions: EPS is an area of unmet research and clinical need. This study provides an agreed definition and core data set for EPS to facilitate further research.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11390/1272966
Citazioni
ND
ND
3
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.